ArticleVascular health and risk management2012

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study.

Assen Goudev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.